Dieter Haemmerich to Xenograft Model Antitumor Assays
This is a "connection" page, showing publications Dieter Haemmerich has written about Xenograft Model Antitumor Assays.
Connection Strength
0.077
-
Development of a radiofrequency ablation platform in a clinically relevant murine model of hepatocellular cancer. Cancer Biol Ther. 2015; 16(12):1812-9.
Score: 0.028
-
Mild hyperthermia triggered doxorubicin release from optimized stealth thermosensitive liposomes improves intratumoral drug delivery and efficacy. J Control Release. 2013 Jun 10; 168(2):142-50.
Score: 0.025
-
Combination therapy of radiofrequency ablation and bevacizumab monitored with power Doppler ultrasound in a murine model of hepatocellular carcinoma. Int J Hyperthermia. 2012; 28(8):766-75.
Score: 0.024